Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

L. Horn; J. G. Whisenant; H. Wakelee; K. L. Reckamp; H. Qiao; L. Du; J. Hernandez; V. Huang; S. N. Waqar; S. Patel; R. E. Sanborn; T. Shaffer; K. Garg; A. Holzhausen; K. Harrow; C. Liang; L. P. Lim; M. Li; C. M. Lovly

doi:10.1093/annonc/mdz063.010

Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

L. Horn, J. G. Whisenant, H. Wakelee, K. L. Reckamp, H. Qiao, L. Du, J. Hernandez, V. Huang, S. N. Waqar, S. Patel, R. E. Sanborn, T. Shaffer, K. Garg, A. Holzhausen, K. Harrow, C. Liang, L. P. Lim, M. Li, C. M. Lovly

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	ii48
Journal	Annals of Oncology
Volume	30
DOIs	https://doi.org/10.1093/annonc/mdz063.010
State	Published - Apr 2019

Access to Document

10.1093/annonc/mdz063.010

Cite this

Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S. N., Patel, S., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L. P., Li, M., & Lovly, C. M. (2019). Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC). Annals of Oncology, 30, ii48. https://doi.org/10.1093/annonc/mdz063.010

@article{912f640f1f3441529c3563ef73f9caa4,

title = "Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)",

author = "L. Horn and Whisenant, {J. G.} and H. Wakelee and Reckamp, {K. L.} and H. Qiao and L. Du and J. Hernandez and V. Huang and Waqar, {S. N.} and S. Patel and Sanborn, {R. E.} and T. Shaffer and K. Garg and A. Holzhausen and K. Harrow and C. Liang and Lim, {L. P.} and M. Li and Lovly, {C. M.}",

year = "2019",

month = apr,

doi = "10.1093/annonc/mdz063.010",

language = "English",

volume = "30",

pages = "ii48",

journal = "Annals of Oncology",

issn = "0923-7534",

}

Horn, L, Whisenant, JG, Wakelee, H, Reckamp, KL, Qiao, H, Du, L, Hernandez, J, Huang, V, Waqar, SN, Patel, S, Sanborn, RE, Shaffer, T, Garg, K, Holzhausen, A, Harrow, K, Liang, C, Lim, LP, Li, M & Lovly, CM 2019, 'Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)', Annals of Oncology, vol. 30, pp. ii48. https://doi.org/10.1093/annonc/mdz063.010

TY - JOUR

T1 - Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

AU - Horn, L.

AU - Whisenant, J. G.

AU - Wakelee, H.

AU - Reckamp, K. L.

AU - Qiao, H.

AU - Du, L.

AU - Hernandez, J.

AU - Huang, V.

AU - Waqar, S. N.

AU - Patel, S.

AU - Sanborn, R. E.

AU - Shaffer, T.

AU - Garg, K.

AU - Holzhausen, A.

AU - Harrow, K.

AU - Liang, C.

AU - Lim, L. P.

AU - Li, M.

AU - Lovly, C. M.

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85079637228&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdz063.010

DO - 10.1093/annonc/mdz063.010

M3 - Article

C2 - 32131242

SN - 0923-7534

VL - 30

SP - ii48

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

Access to Document

Other files and links

Cite this